Dermata Therapeutics(DRMA) - 2022 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OFTHE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 Commission File Number: 001-40739 | --- | |-------| | | | | | | | | | | | | | | | | | | DERMATA THERAPEUTICS, INC. (Exact name of registrant as specified in the charter) Delaware (State or other jurisdiction of incorporation or organization) 3525 Del Mar Heights Rd., #322, San Diego, CA 921 ...